Exelixis, Inc. (EXEL) Cash Flow Statement

NASDAQ: EXELOperating cash, capex, free cash flow and buybacks.

Where EXEL’s cash came from and went, 2025

December 31, 2025 · U.S. dollars
Cash from operations
$884.3M
+26.3% vs 2024
Capital expenditures
$39.9M
1.7% of revenue
Free cash flow
$844.3M
36.4% margin
Returned to shareholders
$947.5M
112% of free cash flow
Change in cash
$265.1M
cash at year-end $482.5M
Cash from operations: $884.3MCash from operations$884.3MInvestments (net): $390.4MInvestments (net)$390.4MShare buybacks: $947.5MShare buybacks$947.5M · 74%Capital expenditures: $39.9MCapital expenditures$39.9M · 3%Added to cash: $265.1MAdded to cash$265.1M · 21%Other financing: $22.1MOther financing$22.1M · 2%$1.27B
Cash from operations
$884.3M
Capital expenditures
−$39.9M
Investments (net)
+$390.4M
Share buybacks (net)
−$947.5M
Other financing
−$22.1M
Change in cash
$265.1M

Drawn to scale: where the cash came from and how it was used. Hover for values.

EXEL operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

EXEL cash flow trends, 2016–2025

Exelixis, Inc. cash flow trends
MetricTrendThenLatestChange
Operating cash flow$206.3M2016$884.3M2025+17.6%/yr
Capital expenditures$1.7M2016$39.9M2025+42.0%/yr
Free cash flow$204.6M2016$844.3M2025+17.1%/yr
Free cash flow margin106.9%201636.4%2025−70.5 pts
Operating cash flow / net income1.0720171.132025+0.06
Stock-based compensation$22.9M2016$113.0M2025+19.4%/yr
Dividends paid$02016$02017—
Share buybacks (net)$4.1M2016$947.5M2025+83.0%/yr
Capex / revenue0.9%20161.7%2025+0.8 pts

Change is the average annual growth (CAGR) or the difference between the first and latest year.

EXEL cash flow by activity

OperatingInvestingFinancingChange in cash

EXEL net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

EXEL cash flow statement

Exelixis, Inc. annual cash flow statement
2025202420232022202120202019201820172016
Operating activities
Net income$782.6M$521.3M$207.8M$182.3M$231.1M$111.8M$321.0M$690.1M$154.2M−$70.2M
Depreciation & amortization$29.1M$28.8M$25.7M$20.9M$13.6M$9.1M$8.3M$7.8M$1.2M$1.0M
Stock-based compensation$113.0M$93.8M$106.3M$107.6M$119.8M$105.1M$56.6M$44.3M$23.9M$22.9M
Change in working capital−$191.2M−$13.5M−$14.0M−$12.8M−$39.0M−$40.1M$67.1M−$79.8M−$6.9M$227.3M
Other non-cash items$150.9M$69.5M$7.5M$64.7M$75.3M$23.1M$73.9M−$246.7M−$6.8M$25.3M
Cash from operating activities$884.3M$700.0M$333.3M$362.6M$400.8M$209.0M$527.0M$415.7M$165.6M$206.3M
Investing activities
Capital expenditures−$39.9M−$66.2M−$163.0M−$138.5M−$64.2M−$30.3M−$12.8M−$33.3M−$21.1M−$1.7M
Investments (net)$390.4M−$116.8M−$334.5M−$386.0M$21.3M−$100.9M−$574.4M−$264.9M$57.8M−$212.9M
Acquisitions & other investing$0$66.2M$470.5M$0$0$0$0$308,000−$836,000−$1.4M
Cash from investing activities$350.4M−$116.8M−$27.0M−$524.4M−$42.9M−$131.2M−$587.2M−$297.9M$35.8M−$216.0M
Financing activities
Dividends paid————————$0$0
Share repurchases & issuance (net)−$947.5M−$652.0M−$550.4M$23.9M−$39.1M−$50.0M−$9.9M−$7.6M−$6.6M−$4.1M
Net borrowing (repayment)———————−$13,000−$185.8M−$575,000
Shares issued$0$0$0$0$0$0$0$0$0$0
Other financing−$22.1M$23.2M$4.3M−$23.3M$24.3M$24.9M$22.5M$17.3M$22.4M$24.5M
Cash from financing activities−$969.6M−$628.8M−$546.1M$586,000−$14.8M−$25.1M$12.6M$9.7M−$169.9M$19.8M
Summary
Net change in cash$265.1M−$45.6M−$239.7M−$161.2M$343.1M$52.6M−$47.7M$127.6M$31.5M$10.1M
Cash at end of period$482.5M$217.4M$263.0M$502.7M$663.9M$320.8M$268.1M$315.9M$183.2M$151.7M
Free cash flow$844.3M$633.8M$170.4M$224.2M$336.6M$178.6M$514.1M$382.4M$144.5M$204.6M
Free cash flow margin36.4%29.2%9.3%13.9%23.5%18.1%53.1%44.8%31.9%106.9%
Capex / revenue1.7%3.1%8.9%8.6%4.5%3.1%1.3%3.9%4.7%0.9%
Operating cash flow / net income1.131.341.601.991.731.871.640.601.07—

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

EXEL cash generation

In fiscal 2025 (ended December 31, 2025), Exelixis generated $884.3 million of cash from operations (up 26.3%) and spent $39.9 million on capital expenditures, leaving free cash flow of $844.3 million, 36.4% of revenue. It returned $947.5 million to shareholders through dividends ($0) and net share buybacks ($947.5 million). Cash and equivalents rose by $265.1 million over the year.

Related: EXEL income statement, EXEL balance sheet. See the EXEL stock overview for the latest quote and news.

EXEL cash flow FAQ

What is Exelixis's free cash flow?

Exelixis's free cash flow was $844.3 million in fiscal 2025: $884.3 million of operating cash flow minus $39.9 million of capital expenditures It was $633.8 million a year earlier..

How much cash does Exelixis generate from operations?

Exelixis generated $884.3 million of cash from operating activities in fiscal 2025, 1.13 times its net income of $782.6 million.

How much does Exelixis spend on capital expenditures?

Exelixis spent $39.9 million on capital expenditures in fiscal 2025, 1.7% of revenue, compared with $66.2 million the year before.

How much stock does Exelixis buy back?

Exelixis spent $947.5 million on net share repurchases in fiscal 2025.

Biotechnology: cash flow